As of 2024-12-15, the Intrinsic Value of Medexus Pharmaceuticals Inc (MDP.TO) is 4.60 CAD. This MDP.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2.90 CAD, the upside of Medexus Pharmaceuticals Inc is 58.60%.

The range of the Intrinsic Value is 3.47 - 6.49 CAD

	Range	Selected	Upside
a
DCF (Growth 5y)	3.47 - 6.49	4.60	58.6%
DCF (Growth 10y)	4.82 - 8.69	6.27	116.1%
DCF (EBITDA 5y)	5.58 - 10.47	7.89	172.2%
DCF (EBITDA 10y)	6.71 - 12.75	9.43	225.3%
Fair Value	0.47 - 0.47	0.47	-83.95%
P/E	2.90 - 2.90	2.90	-0.1%
EV/EBITDA	8.56 - 20.27	14.08	385.5%
EPV	0.10 - 0.72	0.41	-85.8%
DDM - Stable	0.53 - 1.17	0.85	-70.7%
DDM - Multi	0.72 - 1.31	0.94	-67.7%